Shailendra J Singh shares AI insights with Amgen India

🤖 AI in Pharma: What Happens to Talent? AI is rapidly reshaping drug discovery, clinical trials, and regulatory processes. While the promise is extraordinary, the disruption to the pharma workforce cannot be ignored. 📊 The reality: - By 2030, AI could automate 30–40% of drug discovery tasks (from target identification to molecule design). - Roles in data analysis, early-stage research, and documentation face the greatest disruption. - At the same time, demand is rising for AI specialists, regulatory strategists, and cross-functional leaders who can translate science + tech into patient outcomes. As I continue my MBA course, Leading with Integrity, I’ve been reflecting on what leadership requires in this moment. AI isn’t just a technological shift; it’s a human shift. Leadership imperatives: - Guide teams with transparency through uncertainty - Invest in reskilling and cross-functional growth - Balance efficiency gains with the responsibility to support people through change - Pharma leaders are not just adopting AI - they are shaping the future of work itself. 💡 What do you think: Should pharma companies do more to reskill existing employees, or will new AI-driven roles demand entirely new talent pipelines? #Pharma #AI #Leadership #MBAJourney #FutureOfWork #Integrity

🤖 AI in Pharma: Speed, Skills, and the Leadership Challenge AI is transforming how we discover new medicines. By 2025, nearly 30% of new drugs could be AI-driven. The opportunity: - AI can reduce drug discovery timelines by up to 70%. - Early-stage molecule screening can now take months instead of years. - Clinical trial design, patient matching, and predictive analytics are becoming faster and more precise. But this acceleration comes with workforce realities: - Research associates, lab technicians, and data analysts are already seeing aspects of their roles automated. - McKinsey estimates 300,000+ pharma and life sciences roles globally may be redefined or displaced in the next decade. This is where leadership comes in. In my MBA course, Leading with Integrity, we’re aiming to explore what it means to guide organizations through disruption. For leaders in pharma, that means: - Adapting to AI as a core capability, not a side project. - Reskilling and redeploying talent so teams evolve with technology. Leading with empathy and trust, ensuring people feel valued even as roles shift. The promise of AI is huge, but the real test is how leaders navigate the human side of change. 💡 Question for you: How can pharma leaders embrace AI while protecting trust and empowering their teams? #Pharma #AI #Leadership #MBAJourney #Integrity #FutureOfWork

𝐕𝐔𝐂𝐀 is old. 𝐅𝐋𝐔𝐗 is the new reality for Indian Pharma. For years, we used 𝐕𝐔𝐂𝐀 (𝐕𝐨𝐥𝐚𝐭𝐢𝐥𝐞, 𝐔𝐧𝐜𝐞𝐫𝐭𝐚𝐢𝐧, 𝐂𝐨𝐦𝐩𝐥𝐞𝐱, 𝐀𝐦𝐛𝐢𝐠𝐮𝐨𝐮𝐬) to describe our world. But let’s be honest — in today’s AI-powered, hyper-connected environment, that feels outdated. What we face today is 𝐅𝐋𝐔𝐗 : 𝐅𝐚𝐬𝐭– AI and digital health are speeding up discovery & decisions.    𝐋𝐢𝐪𝐮𝐢𝐝 – Boundaries between pharma, tech, and healthcare are dissolving. 𝐔𝐧𝐜𝐡𝐚𝐫𝐭𝐞𝐝 – There’s no map for where global markets or regulations will move next.  𝐞𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭𝐚𝐥– We learn by testing, failing fast, and adapting. And this shift isn’t just theory. For Indian Pharma, it’s playing out right now: AI-driven R&D can bring drugs to market quicker than ever. Global growth depends on navigating fast-changing regulations. Partnerships with tech and academia are becoming growth engines. Upskilling teams to work with AI and data is no longer optional. 👉 The takeaway? Companies that embrace 𝐅𝐋𝐔𝐗 thinking will not just survive — they’ll lead. Those who stay stuck in 𝐕𝐔𝐂𝐀 mindsets may be left behind. 𝐈𝐧𝐝𝐢𝐚’𝐬 𝐩𝐡𝐚𝐫𝐦𝐚 𝐬𝐞𝐜𝐭𝐨𝐫 𝐡𝐚𝐬 𝐬𝐜𝐚𝐥𝐞, 𝐭𝐚𝐥𝐞𝐧𝐭, 𝐚𝐧𝐝 𝐚𝐦𝐛𝐢𝐭𝐢𝐨𝐧. 𝐍𝐨𝐰 𝐢𝐭 𝐧𝐞𝐞𝐝𝐬 𝐚𝐠𝐢𝐥𝐢𝐭𝐲, 𝐚𝐝𝐚𝐩𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲, 𝐚𝐧𝐝 𝐜𝐨𝐮𝐫𝐚𝐠𝐞 𝐭𝐨 𝐞𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭 𝐭𝐨 𝐭𝐫𝐮𝐥𝐲 𝐥𝐞𝐚𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐀𝐈 𝐞𝐫𝐚. #Pharma #Innovation #AI #DigitalHealth #Leadership #FutureOfWork Cipla Dr. Reddy's Laboratories Glenmark Pharmaceuticals Lupin MANKIND PHARMA LTD SUN PHARMA Zydus Group Emcure Pharmaceuticals Limited GSK

TATA SONS LIMITED Executive Chairman N. Chandrasekaran recently highlighted that India is at a crucial moment to leverage AI for the nation’s growth. Speaking at the release of the AI Roadmap for Viksit Bharat, he emphasized that industry, government, and society must work together to unlock AI’s full potential. Chandrasekaran stressed that AI should benefit every sector—from financial services and healthcare to agriculture, pharmaceuticals, and advanced manufacturing. He called for fully integrated AI solutions to drive economic growth and empower SMEs, create jobs, and boost entrepreneurship. He also highlighted the importance of skilling India’s youth for an AI-driven future and using technology to address fundamental challenges in healthcare, education, and other areas, ensuring opportunity, empowerment, and reduced inequalities. “In order to do that, the government, industry, and society at large have to work together in leveraging AI,” he concluded. #tatasons #Chandrasekaran #chairman #government #AI #ArtificialIntelligence #viksitbharat #industry #growth

Takeda established an innovation centre in Bengaluru, dubbed India's "Silicon Valley", earlier this year to tap the country's tech talent to power its global digital transformation.The centre is expanding to have 750 staff working in AI, data science, engineering, and design, from just over 500 employees currently.

ManpowerGroup's Greg Coir shares timely insights in this new BioSpace feature exploring how pharma is responding to industry challenges with increased investment in AI. With 85% of companies ramping up AI efforts, Greg highlights how strategic innovation and adaptability are driving meaningful change in the life sciences space. #AIinPharma #LifeSciences #Leadership #Innovation #BioSpace

ManpowerGroup's Greg Coir shares timely insights in this new BioSpace feature exploring how pharma is responding to industry challenges with increased investment in AI. With 85% of companies ramping up AI efforts, Greg highlights how strategic innovation and adaptability are driving meaningful change in the life sciences space. #AIinPharma #LifeSciences #Leadership #Innovation #BioSpace

ManpowerGroup's Greg Coir shares timely insights in this new BioSpace feature exploring how pharma is responding to industry challenges with increased investment in AI. With 85% of companies ramping up AI efforts, Greg highlights how strategic innovation and adaptability are driving meaningful change in the life sciences space. #AIinPharma #LifeSciences #Leadership #Innovation #BioSpace

🚀✨ 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗼𝗿 𝗜𝗻𝗱𝗶𝗮’𝘀 𝗔𝗜 𝗙𝘂𝘁𝘂𝗿𝗲! 🇮🇳🤖 Chiseled.ai is proud to highlight OpenAI’s announcement of its first-ever India office in New Delhi, set to open later this year! This marks a monumental milestone - not just for AI technology, but for India's booming tech ecosystem, education, healthcare, and business sectors. 𝗪𝗵𝘆 𝗶𝘁 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: 📚🌟 𝙀𝙢𝙥𝙤𝙬𝙚𝙧𝙞𝙣𝙜 𝙀𝙙𝙪𝙘𝙖𝙩𝙞𝙤𝙣: With India leading as the biggest global user of AI learning tools, OpenAI’s local presence will fuel innovation and accessibility for students and educators nationwide. 🏢📈 𝘿𝙧𝙞𝙫𝙞𝙣𝙜 𝘽𝙪𝙨𝙞𝙣𝙚𝙨𝙨 𝙂𝙧𝙤𝙬𝙩𝙝: Indian enterprises can now expect closer collaboration and AI-driven solutions to accelerate recruitment, agriculture, governance, and more. 🩺💡 𝘽𝙤𝙤𝙨𝙩𝙞𝙣𝙜 𝙃𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣: Enhanced AI tools hold transformative potential for diagnostics, mental health, and personalized care—right at our doorstep. 🌍🔗 𝘽𝙪𝙞𝙡𝙙𝙞𝙣𝙜 𝙄𝙣𝙙𝙞𝙖’𝙨 𝙂𝙡𝙤𝙗𝙖𝙡 𝘼𝙄 𝙇𝙚𝙖𝙙𝙚𝙧𝙨𝙝𝙞𝙥: The partnership aligns with the IndiaAI mission, emphasizing trusted, inclusive, and accessible AI that serves communities across the country. At Chiseled.ai, we believe this expansion signals a new era—where cutting-edge AI innovation meets India’s unparalleled talent and spirit. Together, let's shape the future of AI-enabled growth and empowerment! 💡🤖 #OpenAI #IndiaAI #ArtificialIntelligence #AIinIndia #TechInnovation #EdTech #HealthTech #BusinessGrowth #DigitalIndia #AIforGood #FutureOfWork #Startups #Innovation #MachineLearning #DeepLearning #ChiseledAI #FutureReadyIndia #AIRevolution #TechEcosystem #Empowerment #AITransformation

Heading to Bangalore for the week to meet investors, sponsors and partners who are building in AI and building responsibly. If you are in Bangalore this week or know someone working in these spaces, I’d love to meet. Tag them in the comments or DM me. Here’s what I am looking forward to: -  Sipping coffee and diving into conversations on AI, leadership, responsible innovation, and education - areas close to my heart and work. - Catch up with fellow entrepreneurs and builders in AI , while we carpool in Bangalore traffic, because that’s always 2 hours BETTER spent. - Exchange ideas on shaping responsible, conscious, human-first AI and the role of communities like She Shapes AI Asia in building this future. #banglore #startupcity